Related references
Note: Only part of the references are listed.Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy
Christina DeFilippo Mack et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
MEASUREMENT ERRORS AND CENSORED STRUCTURAL LATENT VARIABLES MODELS
Songnian Chen et al.
ECONOMETRIC THEORY (2012)
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
Joseph V. Terza et al.
JOURNAL OF HEALTH ECONOMICS (2008)
Discrete-time survival mixture analysis
B Muthén et al.
JOURNAL OF EDUCATIONAL AND BEHAVIORAL STATISTICS (2005)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance
T Loeys et al.
BIOMETRICS (2003)
Evaluation and extensions of a structural equation modeling approach to the analysis of survival data
SF Posner et al.
BEHAVIOR GENETICS (2000)
Share Paper
